Predictors of poor response to methotrexate in polyarticular-course juvenile idiopathic arthritis: analysis of the PRINTO methotrexate trial
Iris Vilca(Istituto Giannina Gaslini), Nicolino Ruperto(Istituto Giannina Gaslini), Flávio Sztajnbok(Universidade Federal do Rio de Janeiro), Antonella Buoncompagni(Istituto Giannina Gaslini), Alberto Martini(Agenzia Regionale Prevenzione e Ambiente della Regione Emilia-Romagna), Angelo Ravelli(Istituto Giannina Gaslini), Sang‐Cheol Bae(Unknown), Yosef Uziel(Meir Medical Center), Bo Magnusson(Karolinska University Hospital), P. Hollingworth(North Bristol NHS Trust), Luana Campos(Universidade de Santo Amaro), Frank Dressler(Medizinische Hochschule Hannover), Michaël Hofer(FORS – Swiss Centre of Expertise in the Social Sciences), O Arguedas, R. Häfner(German Center for Pediatric and Adolescent Rheumatology), Seza Özen(Hacettepe University), Gail Dunkel Cawkwell, Christian Huemer, B. Bica(Hospital Universitário Clementino Fraga Filho), Marion A. J. van Rossum(Reade), María Luz Gámir Gámir(Hospital Universitario Ramón y Cajal), Pablo García Munitis(Istituto Giannina Gaslini), Angela Pistorio(Istituto Giannina Gaslini), H.‐I. Huppertz(Prof. Hess Kinderklinik), Ivan Foeldvari(Center for Rheumatology)
Cited by 63
Related Papers
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
|Annals of the Rheumatic Diseases|2012|1k
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis
|Nature Genetics|2012|960
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913